首都医科大学学报 ›› 2008, Vol. 29 ›› Issue (2): 109-112.

• 专题报道 • 上一篇    下一篇

TRAIL及其受体的研究进展

陈文明   

  1. 首都医科大学附属北京朝阳医院血液与肿瘤科
  • 收稿日期:2008-01-18 修回日期:1900-01-01 出版日期:2008-04-24 发布日期:2008-04-24

Role of TRAIL and its Receptors in Apoptosis of Tumor

Chen Wenming   

  1. Department of Hematology and Oncology, Beijing Chaoyang Hospital, Capital Medical University
  • Received:2008-01-18 Revised:1900-01-01 Online:2008-04-24 Published:2008-04-24

Abstract: Tumour necrosis factor(TNF)-related apoptosis-inducing ligand(TRAIL) is a member of the TNF superfamily which selectively induces apoptosis in a broad range of cancer cell lines, but not in many normal cells. TRAIL induces apoptosis by activating Caspases and the mitochondrial-dependent apoptotic pathway. Cell death induced by TRAIL can be blocked by a dominant-negative TRAIL receptor, decoy receptors(DcR), and is regulated by members of the Bcl-2 family of proteins. This review is focused on the apoptotic signaling pathways regulated by TRAIL and summarizes what is known about their clinical role.